- Title
- Outcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine
- Creators
- Kimberly Y SMITH - Department of Medicine Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois, United StatesCamlin TIERNEY - Statistical Data Analysis Center, Harvard School of Public Health, Boston, Massachusetts, United StatesMargaret FISCHL - Department of Internal Medicine, University of Miami, Florida, United StatesEric S DAAR - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United StatesAnn C COLLIER - Department of Medicine, Division of Infectious Diseases, University of Washington Medical Center, Seattle, United StatesKatie MOLLAN - Statistical Data Analysis Center, Harvard School of Public Health, Boston, Massachusetts, United StatesCharles S VENUTO - Center for Human Experimental Therapeutics, University of Rochester, New York, United StatesChakra BUDHATHOKI - Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United StatesQING QING MA - Department of Pharmacy Practice, University of Buffalo, State University of New York, United StatesGene D MORSE - School of Pharmacy and Pharmaceutical Sciences, University of Buffalo, State University of New York, United StatesPaul SAX - Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United StatesDavid KATZENSTEIN - School of Medicine, Division of Infectious Diseases, Stanford University, California, United StatesCatherine GODFREY - Division of AIDS, National Institutes of Health, Bethesda, Maryland, United States
- Publication Details
- Clinical infectious diseases, Vol.58(4), pp.555-563
- Publisher
- Oxford University Press; Oxford
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Infectious Diseases
- Language
- English
- Resource Type
- Journal article
- PMID
- 24253247
- PMCID
- PMC3905755
- Record Identifier
- 991031577023302976
Journal article
Outcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine
Clinical infectious diseases, Vol.58(4), pp.555-563
2014
PMCID: PMC3905755
PMID: 24253247
Metrics
5 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.66 HIV
- 1.66.1372 Lipodystrophy
- Web Of Science research areas
- Immunology
- Infectious Diseases
- Microbiology
- ESI research areas
- Immunology
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites